Elsevier

Ophthalmology

Volume 104, Issue 5, May 1997, Pages 799-807
Ophthalmology

International Applicability of the VF-14: An Index of Visual Function in Patients with Cataracts

https://doi.org/10.1016/S0161-6420(97)30230-9Get rights and content

Abstract

Purpose: There is increased recognition that a rigorous approach to functional assessment should complement the assessment of clinical status. The authors compare the reliability, validity, and responsiveness to clinical change of a visual function index (VF-14) in non-U.S. and in U.S. patients with cataracts.

Design: An observational longitudinal study was performed.

Participants: One thousand four hundred seven first eye cataract surgery patients were recruited in four international sites: Manitoba (Canada), Denmark, Barcelona (Spain), and the United States.

Intervention: Patients were evaluated before cataract surgery and at a 4-month postoperative follow-up visit. Patients completed the preoperative interview and the clinical examination (766 in the United States, 152 in Manitoba, 291 in Denmark, and 198 in Barcelona), and 91.3% of those (1284) also completed the 4-month postoperative follow-up interview and were evaluated postoperatively by an ophthalmologist.

Main Outcome Measures: The authors used the following measures: the visual function index (VF-14), the Sickness Impact Profile (SIP), global measures of patients' trouble and satisfaction with vision, and best-corrected visual acuity (VA) in each eye.

Results: The VF-14 showed a high internal consistency reliability level in all sites (Cronbach's alpha coefficients ≥ 0.84). Correlation of preoperative visual function index scores with the Vision-Related SIP was strong (r = -0.68 in non-U.S. and r = -0.57 in U.S. patients) and with VA in the eye with better vision was moderate (r = 0.40 and r = 0.27, respectively), the pattern of relationships being very similar among U.S. and non-U.S. patients. In patients with only first-eye surgery who reported that their initial trouble with vision had improved, the amount of change in visual function as assessed by the VF-14 (effect size) was large (1.01 for the non-U.S. patients and 1.17 for the U.S. patients).

Conclusions: The non-U.S. versions of the visual function index (VF-14) analyzed are as reliable, valid, and responsive to clinical change as the original U.S. version. These versions are appropriate for international studies of cataract patients outcomes and possibly in routine clinical practice.

References (23)

  • EP Steinberg et al.

    The VF-14: an index of functional impairment in patients with cataract

    Arch Ophthalmol

    (1994)
  • Cited by (153)

    • The cataract, a common condition

      2018, Actualites Pharmaceutiques
    • Measurement of visual function among patients undergoing corneal transplantation using the VF-14 index in Morocco

      2016, Journal Francais d'Ophtalmologie
      Citation Excerpt :

      For patients with cataract, these adaptations are as reliable, valid, and sensitive to change as the original American-English version [11,16,17]. It is reported that the fidelity with regard to the original version and the test-retest reproducibility were high for the Canadian-French adaptation of the VF-14 [18]. The VF-14 has also been validated for use with other eye conditions such as glaucoma retinal and corneal diseases [6–8].

    • Clinical practice variation in cataract surgery

      2015, Archivos de la Sociedad Espanola de Oftalmologia
    View all citing articles on Scopus

    Supported in part by a Grant from the Agency for Health Care Policy and Research (No. HS 07085), Washington, DC.

    The Spanish team was supported additionally by grants from the Fondo de Investigacion Sanitaria (FIS) (Expte. No. 9510229), Madrid, Spain, and from the Agencia d' Avaluacio de Tecnologia Medica de Catalunya, Barcelona, Spain.

    The Danish team was supported additionally by the John & Birthe Meyer Foundation, the Danish Eye Research Foundation, the Danish Medical Research Council, the Health Insurance Fond (Denmark), and the Denmark's Health Foundation, Copenhagen, Denmark.

    View full text